Ontology highlight
ABSTRACT:
SUBMITTER: Gatti-Mays ME
PROVIDER: S-EPMC4777638 | biostudies-literature | 2016 Mar
REPOSITORIES: biostudies-literature
Gatti-Mays Margaret E ME Venzon David D Galbo Claudia E CE Singer Andrea A Reynolds James J Makariou Erini E Kallakury Bhaskar B Heckman-Stoddard Brandy M BM Korde Larissa L Isaacs Claudine C Warren Robert R Gallagher Ann A Eng-Wong Jennifer J
Cancer prevention research (Philadelphia, Pa.) 20160112 3
This phase II trial evaluated clinical markers of efficacy and safety of exemestane in postmenopausal women at increased risk for breast cancer. Postmenopausal women (n = 42) at risk for invasive breast cancer received 25 mg exemestane daily for 2 years along with calcium and vitamin D. The primary outcome was change in mammographic density (MD) after one year. Secondary outcomes included change in serum steroid hormones as well as change in trefoil protein 1 (TFF1) and proliferating cell nuclea ...[more]